Bicara Therapeutics Inc. Entity Common Stock, Shares Outstanding from Q3 2024 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Bicara Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2024 to Q3 2025.
  • Bicara Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2025 was 54.8M shares, a 0.67% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)

Bicara Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 54.8M +366K +0.67% Nov 5, 2025 10-Q 2025-11-10
Q2 2025 54.6M Aug 6, 2025 10-Q 2025-08-12
Q1 2025 54.5M Mar 24, 2025 10-K 2025-03-27
Q3 2024 54.4M Nov 8, 2024 10-Q 2024-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.